Last updated: 07/21/2020 17:20:05
Active Lupus in Canada
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Active Lupus in Canada
Trial description: The aim of this study is to describe the prevalence of lupus patients in the Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS) database stratified by levels of disease activity, as well as their clinical characteristics and disease-related outcomes over time.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Prevalence of lupus patients in the CaNIOS cohort
Timeframe: 2005-2014
Description of clinical characteristics of lupus patients in the CaNIOS cohort
Timeframe: 2005-2014
Secondary outcomes:
Description of clinical disease progression of lupus patients in the CaNIOS cohort
Timeframe: 2005-2014
Interventions:
Not applicable
Enrollment:
1400
Primary completion date:
2016-30-12
Observational study model:
Cohort
Time perspective:
Retrospective
Clinical publications:
Christine A Peschken, Yishu Wang, Michal Abrahamowicz, Janet Pope, Earl Silverman, Amyn Sayani, Sandra Iczkovitz, Jorge Ross, Michel Zummer, Lori Tucker, Christian Pineau, Deborah Levy, Marie Hudson, Carol A. Hitchon, Adam M. Huber, C. Douglas Smith, Antonio Avina-Zubieta, Hector Arbillaga, Gaëlle Chedeville, Willy Wynant, Paul R. Fortin.Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus Erythematosus.J Rheumatol.2019;46(2):166-175
DOI: 10.3899/jrheum.171454
PMID: 30219771
Medical condition
Systemic Lupus Erythematosus
Product
belimumab
Collaborators
Not applicable
Study date(s)
August 2014 to December 2016
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
Not applicable
Accepts healthy volunteers
none
- Patients in the CaNIOS cohort
- N/A
Inclusion and exclusion criteria
Inclusion criteria:
- Patients in the CaNIOS cohort
Exclusion criteria:
- N/A
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Study complete
Actual primary completion date
2016-30-12
Actual study completion date
2016-30-12
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website